For the second time in the past year, the lower house of the Chilean congress passed a resolution instructing the government to make it possible to issue compulsory licenses for medicines, but this time, the effort is focused specifically on hepatitis C treatments.

The move comes in response to concerns over rising prices and the ability of the government to cover costs, according to the resolution, and follows a move last month by more than two dozen advocacy groups from around the world to press the health ministry to take action.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Forgive stupid question, but why is no login for my Stat+ subscription possible on Safari on my iPad? Seriously, nowhere on page is there a log-in. Browsers on laptop all work fine but not ipad. Thanks for any help.

Your daily dose of news in health and medicine

Privacy Policy